TORONTO, May 10 /PRNewswire-FirstCall/ - Tm Bioscience Corporation will release financial results for its first quarter on Monday, May 15th, 2006 before market open. Following the release, Tm Bioscience will hold an analyst conference call at 8:00 am (EST) hosted by Mr. Greg Hines, President and CEO, and Mr. Jim Pelot, CFO and COO.
DATE: May 15th, 2006 TIME: 8:00 am, Eastern Standard Time WEBCAST: A live audio webcast of the call will be available at www.tmbioscience.com. Webcast attendees are welcome to listen to the conference in real-time or on-demand at your convenience. The webcast will be archived for 90 days. Please connect to this website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be needed to hear the webcast. About Tm Bioscience - Putting the Human Genome to Work(TM)
Tm Bioscience is a DNA-based diagnostics company developing a suite of genetic tests. Tm Bioscience's product pipeline includes tests for genetic disorders, drug metabolism, and infectious diseases. Tm Bioscience is located in Toronto, Ontario. Additional information about Tm Bioscience can be found at www.tmbioscience.com.
Forward-Looking Statements
This press release contains forward-looking statements, which by their nature necessarily involve risk and uncertainties that could cause the actual results to differ materially from those contemplated by such statements. Tm Bioscience considers the assumptions on which these forward-looking statements are based to be reasonable at the time they were prepared, but cautions readers that these assumptions may ultimately prove to be incorrect due to certain risks and uncertainties including, without limitation, the difficulty of predicting regulatory approvals, market acceptance and demand for new products, the availability of appropriate genetic content and other materials required for Tm Bioscience's products, Tm Bioscience's ability to manufacture its products on a large scale, the protection of intellectual property connected with genetic content, the impact of competitive products, currency fluctuations, risks associated with Tm Bioscience's manufacturing facility and any other similar or related risks and uncertainties. If any of these risks or uncertainties were to materialize, or if assumptions underlying the forward- looking statements of management were to prove incorrect, actual results of Tm Bioscience could vary materially from those that are expressed or implied by these forward-looking statements. Tm Bioscience disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Tm BioscienceCONTACT: In Canada: James Smith, The Equicom Group, Investor and MediaInquiries, (416) 815-0700 ext.229, (416) 815-0080 (fax),jsmith@equicomgroup.com; To request a free copy of this organization'sannual report, please go to http://www.newswire.ca and click on Tools forInvestors.